RS
FOLD

R Squared’s Amicus Therapeutics FOLD Stock Holding History

R Squared’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$219K Buy
15,178
+1,390
+10% +$19.9K 0.12% 293
2025
Q4 		$196K Sell
13,788
-12,036
-47% -$118K 0.09% 368
2025
Q3 		$203K Buy
25,824
+11,636
+82% +$82.8K 0.09% 377
2025
Q2 		$81.3K Buy
+14,188
New +$91.6K 0.04% 364
2025
Q1 		– Sell
-8,410
Closed -$79.2K – 722
2024
Q4 		$79.2K Buy
+8,410
New +$87.4K 0.08% 330

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

R Squared's FOLD Position: Q1 2026 in Review

R Squared increased its Amicus Therapeutics (FOLD) stake by 10% in Q1 2026, buying an estimated $19.9K and bringing the position to 15,178 shares worth $219K. The position accounts for 0.12% of the portfolio, ranked #293.

R Squared first reported a position in FOLD in Q4 2024 and has held it in 5 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • R Squared held 15,178 shares of Amicus Therapeutics worth $219K as of Q1 2026.
  • R Squared bought 1,390 Amicus Therapeutics shares in Q1 2026, an estimated $19.9K.
  • Amicus Therapeutics made up 0.12% of R Squared's portfolio in Q1 2026, its #293 holding.
  • R Squared first reported a position in Amicus Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.